Correlation Between Mineralys Therapeutics, and Bavarian Nordic

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Bavarian Nordic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Bavarian Nordic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Bavarian Nordic AS, you can compare the effects of market volatilities on Mineralys Therapeutics, and Bavarian Nordic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Bavarian Nordic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Bavarian Nordic.

Diversification Opportunities for Mineralys Therapeutics, and Bavarian Nordic

0.07

Correlation Coefficient

Mineralys Therapeutics,  Bavarian Nordic

Significant diversification

The 3 months correlation between Mineralys and Bavarian is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Bavarian Nordic AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bavarian Nordic AS and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Bavarian Nordic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bavarian Nordic AS has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Bavarian Nordic go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Bavarian Nordic

Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 1.18 times less return on investment than Bavarian Nordic. In addition to that, Mineralys Therapeutics, is 1.18 times more volatile than Bavarian Nordic AS. It trades about 0.01 of its total potential returns per unit of risk. Bavarian Nordic AS is currently generating about 0.01 per unit of volatility. If you would invest  1,051  in Bavarian Nordic AS on September 24, 2024 and sell it today you would lose (155.00) from holding Bavarian Nordic AS or give up 14.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	94.97%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Bavarian Nordic AS

Mineralys Therapeutics,

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Mineralys Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Bavarian Nordic AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bavarian Nordic AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Mineralys Therapeutics, and Bavarian Nordic

The main advantage of trading using opposite Mineralys Therapeutics, and Bavarian Nordic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Bavarian Nordic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bavarian Nordic will offset losses from the drop in Bavarian Nordic's long position.

The idea behind Mineralys Therapeutics, Common and Bavarian Nordic AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.